The acidic domain of the endothelial membrane protein GPIHBP1 stabilizes lipoprotein lipase activity by preventing unfolding of its catalytic domain

  1. Simon Mysling
  2. Kristian Kølby Kristensen
  3. Mikael Larsson
  4. Anne P Beigneux
  5. Henrik Gårdsvoll
  6. Fong G Loren
  7. André Bensadouen
  8. Thomas JD Jørgensen
  9. Stephen G Young
  10. Michael Ploug  Is a corresponding author
  1. Rigshospitalet, Denmark
  2. University of California, Los Angeles, United States
  3. Rigshospitalet, United States
  4. Cornell University, United States
  5. University of Southern Denmark, Denmark

Abstract

GPIHBP1 is a glycolipid-anchored membrane protein of capillary endothelial cells that binds lipoprotein lipase (LPL) within the interstitial space and shuttles it to the capillary lumen. The LPL•GPIHBP1 complex is responsible for margination of triglyceride-rich lipoproteins along capillaries and their lipolytic processing. The current work conceptualizes a model for the GPIHBP1•LPL interaction based on biophysical measurements with hydrogen-deuterium exchange/mass spectrometry, surface plasmon resonance, and zero-length cross-linking. According to this model, GPIHBP1 is comprised of two functionally distinct domains: (1) an intrinsically disordered acidic N-terminal domain; and (2) a folded C-terminal domain that tethers GPIHBP1 to the cell membrane by glycosylphosphatidylinositol. We demonstrate that these domains serve different roles in regulating the kinetics of LPL binding. Importantly, the acidic domain stabilizes LPL catalytic activity by mitigating the global unfolding of LPL's catalytic domain. This study provides a conceptual framework for understanding intravascular lipolysis and GPIHBP1 and LPL mutations causing familial chylomicronemia.

Article and author information

Author details

  1. Simon Mysling

    Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark
    Competing interests
    No competing interests declared.
  2. Kristian Kølby Kristensen

    Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark
    Competing interests
    No competing interests declared.
  3. Mikael Larsson

    Department of Medicine, University of California, Los Angeles, Los Angeles, United States
    Competing interests
    No competing interests declared.
  4. Anne P Beigneux

    Department of Medicine, University of California, Los Angeles, Los Angeles, United States
    Competing interests
    No competing interests declared.
  5. Henrik Gårdsvoll

    Finsen Laboratory, Rigshospitalet, Copenhagen, United States
    Competing interests
    No competing interests declared.
  6. Fong G Loren

    Department of Medicine, University of California, Los Angeles, Loa Angeles, United States
    Competing interests
    No competing interests declared.
  7. André Bensadouen

    Division of Nutritional Science, Cornell University, Ithaca, United States
    Competing interests
    No competing interests declared.
  8. Thomas JD Jørgensen

    Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark
    Competing interests
    No competing interests declared.
  9. Stephen G Young

    Department of Medicine, University of California, Los Angeles, Los Angeles, United States
    Competing interests
    Stephen G Young, Reviewing editor, eLife.
  10. Michael Ploug

    Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark
    For correspondence
    m-ploug@finsenlab.dk
    Competing interests
    No competing interests declared.

Reviewing Editor

  1. Christopher K. Glass, University of California, San Diego, United States

Version history

  1. Received: October 5, 2015
  2. Accepted: January 2, 2016
  3. Accepted Manuscript published: January 3, 2016 (version 1)
  4. Version of Record published: February 3, 2016 (version 2)
  5. Version of Record updated: May 9, 2016 (version 3)

Copyright

© 2016, Mysling et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,189
    views
  • 543
    downloads
  • 61
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Simon Mysling
  2. Kristian Kølby Kristensen
  3. Mikael Larsson
  4. Anne P Beigneux
  5. Henrik Gårdsvoll
  6. Fong G Loren
  7. André Bensadouen
  8. Thomas JD Jørgensen
  9. Stephen G Young
  10. Michael Ploug
(2016)
The acidic domain of the endothelial membrane protein GPIHBP1 stabilizes lipoprotein lipase activity by preventing unfolding of its catalytic domain
eLife 5:e12095.
https://doi.org/10.7554/eLife.12095

Share this article

https://doi.org/10.7554/eLife.12095

Further reading

    1. Structural Biology and Molecular Biophysics
    Nicholas James Ose, Paul Campitelli ... Sefika Banu Ozkan
    Research Article

    We integrate evolutionary predictions based on the neutral theory of molecular evolution with protein dynamics to generate mechanistic insight into the molecular adaptations of the SARS-COV-2 spike (S) protein. With this approach, we first identified candidate adaptive polymorphisms (CAPs) of the SARS-CoV-2 S protein and assessed the impact of these CAPs through dynamics analysis. Not only have we found that CAPs frequently overlap with well-known functional sites, but also, using several different dynamics-based metrics, we reveal the critical allosteric interplay between SARS-CoV-2 CAPs and the S protein binding sites with the human ACE2 (hACE2) protein. CAPs interact far differently with the hACE2 binding site residues in the open conformation of the S protein compared to the closed form. In particular, the CAP sites control the dynamics of binding residues in the open state, suggesting an allosteric control of hACE2 binding. We also explored the characteristic mutations of different SARS-CoV-2 strains to find dynamic hallmarks and potential effects of future mutations. Our analyses reveal that Delta strain-specific variants have non-additive (i.e., epistatic) interactions with CAP sites, whereas the less pathogenic Omicron strains have mostly additive mutations. Finally, our dynamics-based analysis suggests that the novel mutations observed in the Omicron strain epistatically interact with the CAP sites to help escape antibody binding.

    1. Structural Biology and Molecular Biophysics
    Marco van den Noort, Panagiotis Drougkas ... Bert Poolman
    Research Article

    Bacteria utilize various strategies to prevent internal dehydration during hypertonic stress. A common approach to countering the effects of the stress is to import compatible solutes such as glycine betaine, leading to simultaneous passive water fluxes following the osmotic gradient. OpuA from Lactococcus lactis is a type I ABC-importer that uses two substrate-binding domains (SBDs) to capture extracellular glycine betaine and deliver the substrate to the transmembrane domains for subsequent transport. OpuA senses osmotic stress via changes in the internal ionic strength and is furthermore regulated by the 2nd messenger cyclic-di-AMP. We now show, by means of solution-based single-molecule FRET and analysis with multi-parameter photon-by-photon hidden Markov modeling, that the SBDs transiently interact in an ionic strength-dependent manner. The smFRET data are in accordance with the apparent cooperativity in transport and supported by new cryo-EM data of OpuA. We propose that the physical interactions between SBDs and cooperativity in substrate delivery are part of the transport mechanism.